Carbapenemases in Germany in 2025 and the impact of changing the isolate submission criteria of the German National Reference Centre for multidrug-resistant Gram-negative bacteria

Niels Pfennigwerth, Sophie Möller, Lisa-Marie Höfken, Soheila Javadi, Sören G. Gatermann

Open source

DOI
10.1016/j.ijmm.2026.151750
Published
2026-12
Container
International Journal of Medical Microbiology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijmm.2026.151750,
  title = {Carbapenemases in Germany in 2025 and the impact of changing the isolate submission criteria of the German National Reference Centre for multidrug-resistant Gram-negative bacteria},
  author = {Niels Pfennigwerth and Sophie Möller and Lisa-Marie Höfken and Soheila Javadi and Sören G. Gatermann},
  year = {2026},
  journal = {International Journal of Medical Microbiology},
  doi = {10.1016/j.ijmm.2026.151750},
  url = {https://doi.org/10.1016/j.ijmm.2026.151750}
}

RIS

TY  - JOUR
TI  - Carbapenemases in Germany in 2025 and the impact of changing the isolate submission criteria of the German National Reference Centre for multidrug-resistant Gram-negative bacteria
AU  - Niels Pfennigwerth
AU  - Sophie Möller
AU  - Lisa-Marie Höfken
AU  - Soheila Javadi
AU  - Sören G. Gatermann
PY  - 2026
JO  - International Journal of Medical Microbiology
DO  - 10.1016/j.ijmm.2026.151750
UR  - https://doi.org/10.1016/j.ijmm.2026.151750
ER  - 

APA

Pfennigwerth, N., Möller, S., Höfken, L., Javadi, S., & Gatermann, S. G. (2026). Carbapenemases in Germany in 2025 and the impact of changing the isolate submission criteria of the German National Reference Centre for multidrug-resistant Gram-negative bacteria. International Journal of Medical Microbiology. https://doi.org/10.1016/j.ijmm.2026.151750

Source records